Literature DB >> 16132362

Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease.

Heejung Kim1, Hyesik Kong, Boim Choi, Youngwook Yang, Youngmi Kim, Mi Jung Lim, Len Neckers, Yunjin Jung.   

Abstract

PURPOSE: Orally administered rutin reportedly ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis of rats. We investigated the metabolic and pharmacological properties of rutin underlying the rutin-mediated amelioration of the rat colitis.
METHODS: Apparent partition coefficients of rutin and its aglycone quercetin were compared. The biochemical/chemical stability of rutin was examined in the contents of various segments of gastrointestinal tracts of rats. Inflammatory indices were determined in the colitis rats after oral administration of rutin or rectal administration of quercetin. In human colon epithelial cells, the effect of quercetin on tumor necrosis factor-alpha (TNF-alpha)-induced nuclear factor kappa B (NFkappaB) activation was examined.
RESULTS: The sugar residue in rutin greatly lowered the apparent partition coefficient and was rapidly deglycosylated to liberate quercetin in the cecal contents, whereas it was stable in the contents of the upper intestine. Not only oral administration of rutin but also rectal administration of quercetin remarkably ameliorated TNBS-induced colitis rats, indicating that quercetin liberated from rutin is therapeutically active. Furthermore, quercetin dose-dependently inhibited an inflammatory signal TNF-alpha-dependent NFkappaB activation.
CONCLUSIONS: Our data suggest that rutin acted as a quercetin deliverer to the large intestine and its anti-inflammatory action in TNBS-induced colitis rats may be through quercetin-mediated inhibition of TNF-alpha-induced NFkappaB activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132362     DOI: 10.1007/s11095-005-6250-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

Review 2.  Role of NF-kappaB in immune and inflammatory responses in the gut.

Authors:  M F Neurath; C Becker; K Barbulescu
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 3.  Metabolism of foreign compounds by gastrointestinal microorganisms.

Authors:  R R Scheline
Journal:  Pharmacol Rev       Date:  1973-12       Impact factor: 25.468

4.  Absorption and disposition kinetics of the dietary antioxidant quercetin in man.

Authors:  P C Hollman; M vd Gaag; M J Mengelers; J M van Trijp; J H de Vries; M B Katan
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

5.  Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta.

Authors:  C K Weber; S Liptay; T Wirth; G Adler; R M Schmid
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

Review 6.  Flavonoids: a review of probable mechanisms of action and potential applications.

Authors:  R J Nijveldt; E van Nood; D E van Hoorn; P G Boelens; K van Norren; P A van Leeuwen
Journal:  Am J Clin Nutr       Date:  2001-10       Impact factor: 7.045

7.  Oral administration of rutoside can ameliorate inflammatory bowel disease in rats.

Authors:  T Cruz; J Gálvez; M A Ocete; M E Crespo; F Sánchez de Medina L-H; A Zarzuelo
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

8.  Absorption, metabolism and health effects of dietary flavonoids in man.

Authors:  P C Hollman; M B Katan
Journal:  Biomed Pharmacother       Date:  1997       Impact factor: 6.529

9.  Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration.

Authors:  Hideki Yano; Fumitoshi Hirayama; Makoto Kamada; Hidetoshi Arima; Kaneto Uekama
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

Review 10.  Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.

Authors:  Toshifumi Hibi; Nagamu Inoue; Haruhiko Ogata; Makoto Naganuma
Journal:  J Gastroenterol       Date:  2003-03       Impact factor: 7.527

View more
  36 in total

Review 1.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

2.  Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.

Authors:  Sarumani Natarajan Suganya; Thangarajan Sumathi
Journal:  Metab Brain Dis       Date:  2016-12-08       Impact factor: 3.584

3.  Thermotolerance and heat acclimation may share a common mechanism in humans.

Authors:  Matthew Kuennen; Trevor Gillum; Karol Dokladny; Edward Bedrick; Suzanne Schneider; Pope Moseley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

Review 4.  Potential neuroprotective biomolecules in ophthalmology.

Authors:  Mehrdad Afarid; Fatemeh Sanie-Jahromi
Journal:  Int Ophthalmol       Date:  2020-11-12       Impact factor: 2.031

5.  Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.

Authors:  Eun-Ha Joh; Dong-Hyun Kim
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 6.  Alternative medicines as emerging therapies for inflammatory bowel diseases.

Authors:  Udai P Singh; Narendra P Singh; Brandon Busbee; H Guan; Balwan Singh; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

Review 7.  Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid.

Authors:  Hossein Hosseinzadeh; Marjan Nassiri-Asl
Journal:  J Endocrinol Invest       Date:  2014-05-31       Impact factor: 4.256

Review 8.  Anthocyanin can arrest the cone photoreceptor degeneration and act as a novel treatment for retinitis pigmentosa.

Authors:  Ye Tao; Tao Chen; Guo-Qing Yang; Guang-Hua Peng; Zhong-Jun Yan; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

9.  Rutin supplementation in the diet has protective effects against toxicant-induced hippocampal injury by suppression of microglial activation and pro-inflammatory cytokines: protective effect of rutin against toxicant-induced hippocampal injury.

Authors:  Tomoko Koda; Yoshiki Kuroda; Hideki Imai
Journal:  Cell Mol Neurobiol       Date:  2009-01-21       Impact factor: 5.046

10.  Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis.

Authors:  Yonghyun Lee; Seongkeun Jeong; Wooseong Kim; Hyunjeong Kim; Jeong-Hyun Yoon; Seong Hoon Jeong; Yunjin Jung
Journal:  Dig Dis Sci       Date:  2012-11-29       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.